Valuation — not yet established
No valuation for PleoPharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($50.3M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for PleoPharma
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $6.2M | ▮ | ▮ |
| May 2022 | Early Stage VC | $11.1M | ▮ | ▮ |
How PleoPharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PleoPharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has PleoPharma raised?
- PleoPharma has raised $50.3M in total funding across 2 recorded rounds.
- When did PleoPharma last raise?
- PleoPharma last raised in Jun 2025 (Early Stage VC), raising $6.2M.